Oxford BioMedica chief seeks to calm fears over patents
Friday 17 March 2000
Oxford Biomedica, the gene therapy group, yesterday broke the UK biotechnology sector's silence on Bill Clinton and Tony Blair's intervention in the gene patenting debate, which has sent shares in the sector tumbling in the last two days.
The company issued a statement seeking to reassure shareholders that comments on Tuesday by Mssrs Clinton and Blair that gene discoveries should not be patented were no threat to its future.
The statement said: "In general, discoveries cannot, and we believe should not, be patented. However, if one takes a discovery and uses it to make a product, the product is a patentable invention. This was clearly endorsed by President Clinton and Tony Blair."
In spite of the statement, Oxford BioMedica's shares closed down 7p at 84.5p.
The company is a pioneer in the field of gene therapy. It uses discoveries in genomics - the mapping of the human genome - to develop proteins which are injected into the body to stimulate genes to perform particular functions. These include genes that kill tumours and stop the replication of HIV, the virus that causes Aids.
Professor Alan Kingsman, Oxford BioMedica's chief executive, said: "I'm not sure Clinton and Blair said anything too bad. It's the way it's been interpreted that's the problem. They recognise the importance of intellectual property rights as a spur to developing new medicines. No new medicine would be developed without a patent to protect it."
He said he issued the statement in response to anxious calls from confused shareholders. "We're a gene-based company - if we weren't going to put the record straight, who would?"
Professor Kingsman said the company already had patents on all the genes it needed for product development for the foreseeable future.
He added: "Ninety per cent of the value of the UK biotechnology sector doesn't lie in things that come out of the Human Genome Project."
educationTo mark International Women's Day, Sarah Brown on how charities have brought proper joined-up thinking to the delivery of education
South African rhino finally put down after roaming Kruger park for days with horn hacked off and bullet in brain
Lammily: Barbie-like doll hits Kickstarter fundraising target in a day
Belle Knox: How a porn star student from Duke University became bigger than Justin Bieber
Oscar Pistorius trial: Neighbour feared South African athlete would use gun that killed his girlfriend Reeva Steenkamp to kill himself
Top 10 most expensive cities in the world: Singapore named costliest place to live – but what about London?
Apple's Tim Cook: Business isn’t just about making profit
Thousands of young people forced to go without food after benefits wrongly stopped under 'draconian' new sanctions regime
Ukraine crisis: New navy chief 'defects' and surrenders Crimean HQ as Putin claims ultranationalists forced intervention
Ukraine crisis: Russia dismisses '3am ultimatum' as 'total nonsense'
If you're horrified by a flame-roasted dog, you should be shocked at a hog roast
Poor 'live like animals' says Boris's privately educated sister after going on 'poverty safari'
- 1 The future of sex: The first female condoms were derided, mistrusted and shunned - but will their modern counterparts catch on?
- 2 South African rhino finally put down after roaming Kruger park for days with horn hacked off and bullet in brain
- 3 Study suggests that 'gaydars' are real - at least for women
- 4 Man stabbed with Legend of Zelda Master Sword in serious condition
- 5 First clip of Outkast's Andre 3000 in Jimi Hendrix biopic All Is By My Side emerges
iJobs Money & Business
£1200 per month: Inspiring Interns: Our client is one of Europes leading mobi...
£18000 - £19000 per annum: Inspiring Interns: Our client is the UKs leading i...
£30000 - £45000 per annum: Inspiring Interns: A (non-bank) fast-growing intern...
£40000 - £80000 per annum + Very Compeititve Salary: Austen Lloyd: Corporate F...